TP53 and cancer: The p53-family of proteins has been analyzed as target of specific autoantibodies in cancer patients using the canonical proteins, except for p53, whose seroreactivity has been also evaluated using the most frequent p53 point mutants found in cancer and different N-terminal and C-terminal deletions of the protein to identify masked epitopes of the cancer autoantigen14.